Arşiv logosu
  • Türkçe
  • English
  • Giriş
    Yeni kullanıcı mısınız? Kayıt için tıklayın. Şifrenizi mi unuttunuz?
Arşiv logosu
  • Koleksiyonlar
  • Sistem İçeriği
  • Analiz
  • Talep/Soru
  • Türkçe
  • English
  • Giriş
    Yeni kullanıcı mısınız? Kayıt için tıklayın. Şifrenizi mi unuttunuz?
  1. Ana Sayfa
  2. Yazara Göre Listele

Yazar "Yararbas O." seçeneğine göre listele

Listeleniyor 1 - 3 / 3
Sayfa Başına Sonuç
Sıralama seçenekleri
  • Küçük Resim Yok
    Öğe
    Does omeprazole effect leukocyte function? [OMEPRAZOL NOTROFIL LOKOSIT FONKSIYONLARINI ETKILER MI?]
    (1996) Coker A.; Coker I.; Kapkac M.; Korkut M.; Guler A.; Yararbas O.
    In this study, in vitro adhesion and chemotaxis of leukocytes have been searched in rabbits. Animals were divided into three groups as control, sepsis and sepsis plus omeprazol. Inhibited in the last group differences between adhesion percentages were nonsignificant. As a result H/K ATPase enzyme system has not only been seen in gastric parietal cells, but also in neutrophils, and omeprazol might effect neutrophil leucocyte functions. That observation needs to be supported by randomized and double blind clinical trials.
  • Küçük Resim Yok
    Öğe
    Is mezlocilline prophylaxis effective in clinical renal transplantation?
    (1992) Tokat Y.; Coker A.; Basci A.; Hoscoskun C.; Kaplan H.; Yararbas O.
    [No abstract available]
  • Küçük Resim Yok
    Öğe
    Posttransplantation malignancies and treatments [Organ transplantasyonu sonrasi gelisen maligniteler ve tedavileri]
    (1999) Akgun E.; Tercan M.; Tokat Y.; Ersin S.; Kaplan H.; Yararbas O.
    Long term immunosuppressive therapy following organ transplantation increases the risk of de novo malignant diseases development. Between 1985 through 1998, a total of 347 renal and 25 liver transplantations performed in Ege University Medical School Hospital, Department of General and Transplantation Surgery were studied retrospectively. During the follow up period, 15 patients with renal transplants and one with liver transplant have developed malignancy. In the management of the malignant diseases; reduction in the immunosuppression regimen for Kaposi's sarcoma, excision for epidermoid carcinoma in situ and basocellular carcinoma in situ, chemotherapy for lymphoma, conisation for cervix carcinoma in situ and modified radical mastectomy and adjuvant chemotherapy for breast carcinoma were performed. Mortality rate was %18.7(3 patients). Most of the malignancies after transplantation are skin related lesion and if they are diagnosed early are curable without organ loss. We suggest to screen all the patients for malignancy closer than the normal population, yearly mammograms, gynecologic examinations, occult blood and rectosigmoidoscopy and biopsy all skin lesion.

| Ege Üniversitesi | Kütüphane | Açık Erişim Politikası | Rehber | OAI-PMH |

Bu site Creative Commons Alıntı-Gayri Ticari-Türetilemez 4.0 Uluslararası Lisansı ile korunmaktadır.


Ege Üniversitesi Rektörlüğü Gençlik Caddesi No : 12 35040 Bornova - İZMİR, TÜRKİYE
İçerikte herhangi bir hata görürseniz lütfen bize bildirin

DSpace 7.6.1, Powered by İdeal DSpace

DSpace yazılımı telif hakkı © 2002-2025 LYRASIS

  • Çerez Ayarları
  • Gizlilik Politikası
  • Son Kullanıcı Sözleşmesi
  • Geri Bildirim